82 FR 10484 - Granting of Request for Early Termination of the Waiting Period Under the Premerger Notification Rules
FEDERAL TRADE COMMISSION Federal Register Volume 82, Issue 28 (February 13, 2017)
Federal Register Volume 82, Issue 28 (February 13, 2017)
| Page Range | 10484-10487 | |
| FR Document | 2017-02892 |
[Federal Register Volume 82, Number 28 (Monday, February 13, 2017)] [Notices] [Pages 10484-10487] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-02892] ======================================================================= ----------------------------------------------------------------------- FEDERAL TRADE COMMISSION Granting of Request for Early Termination of the Waiting Period Under the Premerger Notification Rules Section 7A of the Clayton Act, 15 U.S.C. 18a, as added by Title II of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, requires persons contemplating certain mergers or acquisitions to give the Federal Trade Commission and the Assistant Attorney General advance notice and to wait designated periods before consummation of such plans. Section 7A(b)(2) of the Act permits the agencies, in individual cases, to terminate this waiting period prior to its expiration and requires that notice of this action be published in the Federal Register. The following transactions were granted early termination--on the dates indicated--of the waiting period provided by law and the premerger notification rules. The listing for each transaction includes the transaction number and the parties to the transaction. The grants were made by the Federal Trade Commission and the Assistant Attorney General for the Antitrust Division of the Department of Justice. Neither agency intends to take any action with respect to these proposed acquisitions during the applicable waiting period. [[Page 10485]] Early Terminations Granted January 1, 2017 Thru January 31, 2017 ------------------------------------------------------------------------ ------------------------------------------------------------------------ 01/03/2017 ------------------------------------------------------------------------ 20170451.................. G IIF US Holding LP; United States Power Fund III, L.P.; IIF US Holding LP. 20170459.................. G Asbury Automotive Group, Inc.; David and Jackie Cox; Asbury Automotive Group, Inc. 20170467.................. G Synchronoss Technologies, Inc.; IntraLinks Holdings, Inc.; Synchronoss Technologies, Inc. 20170474.................. G Desmarais Family Residuary Trust; Performance Sports Group Ltd.; Desmarais Family Residuary Trust. 20170475.................. G Fairfax Financial Holdings Limited; Performance Sports Group Ltd.; Fairfax Financial Holdings Limited. 20170477.................. G West Street Capital Partners VII, L.P.; The Goldman Sachs Group, Inc.; West Street Capital Partners VII, L.P. 20170478.................. G West Street Capital Partners VII, L.P.; Altor Holding AB; West Street Capital Partners VII, L.P. 20170479.................. G Sterling Investment Partners III, L.P.; Belnick, Inc.; Sterling Investment Partners III, L.P. 20170482.................. G Quantum Energy Partners V, LP; Gulfport Energy Corporation; Quantum Energy Partners V, LP. 20170484.................. G Sumitomo Corporation; Fyffes plc; Sumitomo Corporation. 20170490.................. G LSF9 Pharaoh L.P.; Halmont Properties Corporation; LSF9 Pharaoh L.P. 20170491.................. G The Hearst Family Trust; David L. Morgan and Milleson M. Morgan; The Hearst Family Trust. 20170493.................. G Nucor Corporation; San Faustin N.V.; Nucor Corporation. 20170500.................. G TPG Partners VII, L.P.; Thoma Bravo Fund X, L.P.; TPG Partners VII, L.P. 20170506.................. G John B. Zachry; Ambitech Engineering Corporation; John B. Zachry. ------------------------------------------------------------------------ 01/04/2017 ------------------------------------------------------------------------ 20170426.................. G China Reform Holdings Corporation Ltd.; Lattice Semiconductor Corporation; China Reform Holdings Corporation Ltd. 20170487.................. G Sika AG; Linda W. Hart and Milledge A. Hart, III; Sika AG. 20170497.................. G Sibanye Gold Limited; Stillwater Mining Company; Sibanye Gold Limited. 20170501.................. G BCP Energy Services Fund, LP; Charles E. Price; BCP Energy Services Fund, LP. ------------------------------------------------------------------------ 01/06/2017 ------------------------------------------------------------------------ 20170432.................. G TCV VIII, L.P.; Payoneer Inc.; TCV VIII, L.P. 20170468.................. G Greenlight Capital, L.P.; General Motors Company; Greenlight Capital, L.P. 20170469.................. G Greenlight Capital (Gold), L.P.; General Motors Company; Greenlight Capital (Gold), L.P. 20170470.................. G Greenlight Capital Re, Ltd.; General Motors Company; Greenlight Capital Re, Ltd. 20170471.................. G Greenlight Capital Offshore (Gold), Ltd.; General Motors Company; Greenlight Capital Offshore (Gold), Ltd. 20170472.................. G Greenlight Capital Qualified, L.P.; General Motors Company; Greenlight Capital Qualified, L.P. 20170473.................. G Greenlight Capital Offshore, Ltd.; General Motors Company; Greenlight Capital Offshore, Ltd. 20170483.................. G NWP HoldCo LLC; Sociedade de Gestao e Financiamentos, S.G.P.S., S.A.; NWP HoldCo LLC. 20170494.................. G KSBP Holdings, LLC; Kendra Scott; KSBP Holdings, LLC. 20170522.................. G Pamlico Capital III, L.P.; LOE Holdings, LLC; Pamlico Capital III, L.P. 20170528.................. G Intel Corporation; There Holding B.V.; Intel Corporation. 20170530.................. G Bain Capital Fund XI, L.P.; Epic/Freedom, LLC; Bain Capital Fund XI, L.P. ------------------------------------------------------------------------ 01/09/2017 ------------------------------------------------------------------------ 20170517.................. G Netmarble Games Corporation; Kabam, Inc.; Netmarble Games Corporation. 20170525.................. G Liberty Mutual Holding Company Inc.; GUO GUANGCHANG; Liberty Mutual Holding Company Inc. 20170529.................. G KKR European Fund IV L.P.; Gfk Verein; KKR European Fund IV L.P. ------------------------------------------------------------------------ 01/10/2017 ------------------------------------------------------------------------ 20170460.................. G H.I.G. Middle Market LBO Fund II, L.P.; Lionbridge Technologies, Inc.; H.I.G. Middle Market LBO Fund II, L.P. 20170502.................. G Global Atlantic Financial Group Limited; Perella Weinberg Partners ABV Opportunity Master Fund III B; Global Atlantic Financial Group Limited. 20170507.................. G Casablanca Holdings L.P.; Bain Capital Fund X, L.P.; Casablanca Holdings L.P. 20170511.................. G New Mountain Partners IV, L.P.; Dr. Barry Arkles; New Mountain Partners IV, L.P. ------------------------------------------------------------------------ 01/11/2017 ------------------------------------------------------------------------ 20170439.................. G Consolidated Communications Holdings, Inc.; FairPoint Communications, Inc.; Consolidated. 20170513.................. G Communications Holdings, Inc. Munksjo Oyj; Ahlstrom Corporation; Munksjo Oyj. ------------------------------------------------------------------------ 01/12/2017 ------------------------------------------------------------------------ 20170458.................. G Novartis AG; Ziarco Group Limited; Novartis AG. 20170496.................. G Novartis AG; Encore Vision, Inc.; Novartis AG. 20170527.................. G WerfenLife, S.A.; Warburg Pincus Private Equity X, L.P.; WerfenLife, S.A. ------------------------------------------------------------------------ 01/13/2017 ------------------------------------------------------------------------ 20170488.................. G Gemalto N.V.; 3M Company; Gemalto N.V. 20170533.................. G Patterson-UTI Energy, Inc.; Seventy Seven Energy Inc.; Patterson-UTI Energy, Inc. 20170535.................. G Welsh Carson Anderson & Stowe XI, LP; Revel Systems, Inc.; Welsh Carson Anderson & Stowe XI, LP. 20170536.................. G AIF VIII Euro Holdings, L.P.; Koninklijke Philips N.V.; AIF VIII Euro Holdings, L.P. 20170538.................. G Alta Resources Development, LLC; Anadarko Petroleum Corporation; Alta Resources Development, LLC. 20170549.................. G Vulcan Materials Company; Jack D. Lowery and Susannah S. Lowery; Vulcan Materials Company. 20170552.................. G Alta Resources Development, LLC; Mitsui & Co. Ltd.; Alta Resources Development, LLC. [[Page 10486]] 20170554.................. G Warburg Pincus Private Equity XII, L.P.; A&M Capital Partners, LP; Warburg Pincus Private Equity XII, L.P. 20170555.................. G Gee Automotive Holdings, LLC; Edward C. Tonkin; Gee Automotive Holdings, LLC. 20170557.................. G Gee Automotive Holdings, LLC; Bradley E. Tonkin; Gee Automotive Holdings, LLC. ------------------------------------------------------------------------ 01/17/2017 ------------------------------------------------------------------------ 20170461.................. G Schweitzer-Manduit International, Inc.; Leucadia National Corporation; Schweitzer- Manduit International, Inc. 20170466.................. G Warburg Pincus Private Equity XI, L.P.; Minnesota Mutual Companies, Inc.; Warburg Pincus Private Equity XI, L.P. 20170518.................. G Golden Gate Capital Opportunity Fund, L.P.; NeuStar, Inc.; Golden Gate Capital Opportunity Fund, L.P. 20170542.................. G Partners Group Client Access 19, L.P. Inc.; Quad-C Partners VII, L.P.; Partners Group Client Access 19, L.P. Inc. 20170547.................. G MMJS Trust; Apache Industrial Holdings, Inc.; MMJS Trust. 20170551.................. G Lonza Group Ltd; CH Holding L.P.; Lonza Group Ltd. 20170558.................. G Thoma Bravo Fund XII, L.P.; PHNTM Holdings, Inc.; Thoma Bravo Fund XII, L.P. ------------------------------------------------------------------------ 01/18/2017 ------------------------------------------------------------------------ 20170464.................. G Sierra Private Investments L.P.; Mitel Networks Corporation; Sierra Private Investments L.P. 20170495.................. G KKR North America Fund, XI, L.P.; Blackstone Capital Partners VI L.P.; KKR North America Fund, XI, L.P. ------------------------------------------------------------------------ 01/19/2017 ------------------------------------------------------------------------ 20170520.................. G Unilever N.V.; Living Proof, Inc.; Unilever N.V. 20170543.................. G Prestige Brands Holdings, Inc.; C.B. Fleet TopCo, LLC; Prestige Brands Holdings, Inc. ------------------------------------------------------------------------ 01/23/2017 ------------------------------------------------------------------------ 20170553.................. G Altor Holding AB; Transcom Worldwide AB; Altor Holding AB. 20170556.................. G Berkshire Hathaway Inc.; Schulz Holding GmbH & Co. KG; Berkshire Hathaway Inc. 20170564.................. G Secondary Opportunities Fund III, LP; Enhanced Equity Fund, L.P.; Secondary Opportunities Fund III, LP. 20170565.................. G Secondary Opportunities Fund III, LP; Enhanced Equity Fund II, L.P.; Secondary Opportunities Fund III, LP. 20170566.................. G Atlassian Corporation Plc; Trello, Inc.; Atlassian Corporation Plc. 20170570.................. G Blackstone Core Equity Partners L.P.; RT SESAC Holdings LP; Blackstone Core Equity Partners L.P. 20170572.................. G Hennessy Capital Acquisition Corp. II; Daseke, Inc.; Hennessy Capital Acquisition Corp. II. 20170574.................. G LTR Group Holdings, LLC; Clearlake Capital Partners IV (AIV-Atlas), L.P.; LTR Group Holdings, LLC. 20170583.................. G Svenska Cellulosa Aktiebolaget SCA; EQT VI (No.1) Limited Partnership; Svenska Cellulosa Aktiebolaget SCA. 20170589.................. G Bain Capital Fund XI, L.P.; J.H. Whitney VII, L.P.; Bain Capital Fund XI, L.P. 20170590.................. G J.H. Whitney VII, L.P.; Bain Capital Fund XI, L.P.; J.H. Whitney VII, L.P. ------------------------------------------------------------------------ 01/24/2017 ------------------------------------------------------------------------ 20170584.................. G KKR Asian Fund II Japan AIV L.P.; Hitachi, Ltd.; KKR Asian Fund II Japan AIV L.P. ------------------------------------------------------------------------ 01/25/2017 ------------------------------------------------------------------------ 20170514.................. G Insight MB Holdings, LLC; Riverside Micro-Cap Fund II, L.P.; Insight MB Holdings, LLC. 20170532.................. G Visa Inc.; CardinalCommerce Corporation; Visa Inc. 20170563.................. G Allergan plc; Chiron Guernsey Holdings L.P. Inc.; Allergan plc. 20170571.................. G Assurant, Inc.; Walter Investment Management Corp.; Assurant, Inc. 20170576.................. G Celgene Corporation; Delinia, Inc.; Celgene Corporation. 20170578.................. G Jorge Paulo Lemann; Agnaten SE; Jorge Paulo Lemann. 20170579.................. G Eugenie Patri Sabastien EPS, SA; Agnaten SE; Eugenie Patri Sabastien EPS, SA. ------------------------------------------------------------------------ 01/26/2017 ------------------------------------------------------------------------ 20170523.................. G First Horizon National Corporation; Coastal Financial Holdings, Inc.; First Horizon National Corporation. ------------------------------------------------------------------------ 01/27/2017 ------------------------------------------------------------------------ 20170334.................. G Oracle Corporation; Dynamic Network Services Inc.; Oracle Corporation. 20170454.................. G CHRISTUS Health; Good Shepherd Health System, Inc.; CHRISTUS Health. 20170595.................. G LSF X International 2, L.P.; Arclin Cayman Holdings Ltd.; LSF X International 2, L.P. 20170597.................. G Fairfax Financial Holdings Limited; Allied World Assurance Company Holdings, AG; Fairfax Financial Holdings Limited. 20170606.................. G Nippon Paint Holdings Co., Ltd.; DE Parent Corp.; Nippon Paint Holdings Co., Ltd. ------------------------------------------------------------------------ 01/30/2017 ------------------------------------------------------------------------ 20170618.................. G L Catterton VIII, L.P.; Leslie's Holdings, Inc.; L Catterton VIII, L.P. 20170621.................. G Ulysses L. Bridgeman, Jr.; The Coca-Cola Company; Ulysses L. Bridgeman, Jr. 20170639.................. G Takeda Pharmaceutical Company Limited; ARIAD Pharmaceuticals, Inc.; Takeda Pharmaceutical Company Limited. ------------------------------------------------------------------------ 01/31/2017 ------------------------------------------------------------------------ 20170540.................. G ArcLight Energy Partners Fund VI, L.P.; Lindsay Goldberg III AIV L.P.; ArcLight Energy Partners Fund. 20170581.................. G VI, L.P. Monomoy Capital Partners II, L.P.; Corinthian Equity Fund, L.P.; Monomoy Capital Partners II, L.P. ------------------------------------------------------------------------ [[Page 10487]] FOR FURTHER INFORMATION CONTACT: Theresa Kingsberry, Program Support Specialist, Federal Trade Commission Premerger Notification Office, Bureau of Competition, Room CC-5301, Washington, DC 20024, (202) 326- 3100. By direction of the Commission. Donald S. Clark, Secretary. [FR Doc. 2017-02892 Filed 2-10-17; 8:45 am] BILLING CODE 6750-01-P
![10484 Federal Register / Vol. 82, No. 28 / Monday, February 13, 2017 / Notices
11, 16, and 19 of the Federal Reserve by the Board or jointly with another information collected will be considered
Act. 12 (U.S.C. 248(i), 248–1, 464). The government agency, a Reserve Bank, or confidential. However, information may
obligation to respond is required for the a private firm. The FR 3054b is an be exempt from disclosure under
institution to obtain the benefit of an annual survey used to assess the quality exemption 4 of the Freedom of
increase in daylight overdraft capacity of currency in circulation and may be Information Act, 5 U.S.C. 552(b)(4), if
beyond the limit afforded by the conducted by the Federal Reserve disclosure would likely have the effect
exempt-from-filing cap. The Board has Board, jointly with the Federal Reserve of (1) impairing the government’s ability
confirmed that the disclosure of Bank of San Francisco’s Cash Product to obtain the necessary information in
information collected on the FR 2226 Office (CPO), the Federal Reserve Bank the future, or (2) causing substantial
would likely cause substantial harm to of Richmond’s Currency Technology harm to the competitive position of the
the competitive position of the Office (CTO), and each Reserve Bank’s respondent. Additionally, should survey
respondent institution. Therefore, the cash department. The FR 3054c is a responses contain any information of a
FR 2226 is exempt from disclosure semiannual survey used to determine private nature the disclosure of which
under exemption (b)(4) of the Freedom depository institutions’ and Banknote would constitute ‘‘a clearly unwarranted
of Information Act (FOIA), which Equipment Manufacturers’ (BEMs) invasion of personal privacy,’’ such
exempts from disclosure ‘‘trade secrets opinions of currency quality and may be information may be exempt from
and commercial or financial information conducted jointly with the CPO and disclosure under exemption 6, 5 U.S.C.
obtained from a person and privileged CTO. The FR 3054d is an annual survey 552(b)(6). Confidentiality matters
or confidential.’’ (5 U.S.C. 552(b)(4)). In used to assess the functionality of should be treated on a case-by-case basis
addition, information reported in Federal Reserve notes in bank-note to determine if any of the above
connection with the second and third handling equipment. The data collected exemptions apply.
resolutions may be protected under from the FR 3054d are used as inputs for Board of Governors of the Federal Reserve
section (b)(8) of FOIA, to the extent that future designs of Federal Reserve notes. System, February 7, 2017.
such information is based on the The FR 3054d may be conducted jointly Robert deV. Frierson,
institution’s CAMELS rating, and thus is with the U.S. Treasury’s Bureau of Secretary of the Board.
related to examination reports prepared Engraving and Printing (BEP) and the
[FR Doc. 2017–02827 Filed 2–10–17; 8:45 am]
by, on behalf of, or for the use of an CTO. The FR 3054a, FR 3054b, FR
BILLING CODE 6210–01–P
agency responsible for the regulation or 3054c, and FR 3054d are sent to
supervision of financial institutions. (5 financial and nonfinancial businesses.
U.S.C. 552(b)(8)). The Federal Reserve Board may use
4. Report title: Ad Hoc Payments the data collected from these surveys to FEDERAL TRADE COMMISSION
Survey (FR 3054a), Currency Quality determine (1) demand for currency and
Sampling Survey (FR 3054b), Currency coin, (2) market preferences regarding Granting of Request for Early
Quality Survey (FR 3054c), and currency quality, (3) quality of currency Termination of the Waiting Period
Currency Functionality and Perception in circulation, (4) features used by the Under the Premerger Notification
Survey (FR 3054d). public and bank note authentication Rules
Agency form number: FR 3054a, FR equipment to denominate and
3054b, FR 3054c, and FR 3054d. authenticate bank notes, and (5) Section 7A of the Clayton Act, 15
OMB control number: 7100–0332 whether changes to Reserve Bank U.S.C. 18a, as added by Title II of the
Frequency: FR 3054a, annually; FR sorting algorithms are necessary to Hart-Scott-Rodino Antitrust
3054b, annually; FR 3054c, semi- ensure that currency in circulation Improvements Act of 1976, requires
annually; and FR 3054d, quarterly. remains fit for commerce. persons contemplating certain mergers
Respondents: Financial, institutions Legal authorization and or acquisitions to give the Federal Trade
(or depository institutions) individuals, confidentiality: The Board’s Legal Commission and the Assistant Attorney
law enforcement and nonfinancial Division has determined that section General advance notice and to wait
businesses (banknote equipment 11(d) of the Federal Reserve Act (12 designated periods before
manufacturers, or global wholesale bank U.S.C. 248(d)) authorizes the Board to consummation of such plans. Section
note dealers). ‘‘supervise and regulate through the 7A(b)(2) of the Act permits the agencies,
Estimated number of respondents: FR Secretary of the Treasury the issue and in individual cases, to terminate this
3054a, 20,000 respondents; FR 3054b, retirement of Federal reserve notes, waiting period prior to its expiration
300 respondents; FR 3054c, 25 except for the cancellation and and requires that notice of this action be
respondents; and FR 3054d, 250 destruction, and accounting with published in the Federal Register.
respondents. respect to such cancellation and The following transactions were
Estimated average hours per response: destruction, of notes unfit for granted early termination—on the dates
FR 3054a, 0.75 hours; FR 3054b, 0.50 circulation, and to prescribe rules and indicated—of the waiting period
hours; FR 3054c, 30 hours; and FR regulations under which such notes may provided by law and the premerger
3054d, 2.50 hours. be delivered by the Secretary of the notification rules. The listing for each
Estimated annual burden hours: FR Treasury to the Federal Reserve agents transaction includes the transaction
3054a, 15,000 hours; FR 3054b, 150 applying therefor.’’ This provision of the number and the parties to the
hours; FR 3054c, 1,500 hours; and FR Federal Reserve Act provides the legal transaction. The grants were made by
3054d, 2,500 hours. authorization for this information the Federal Trade Commission and the
jstallworth on DSK7TPTVN1PROD with NOTICES
General Description of Report: The FR collection. The obligation to respond to Assistant Attorney General for the
3054a is an event-driven survey used to the FR 3054a, FR 3054b, FR 3054c, and Antitrust Division of the Department of
obtain information specifically tailored FR 3054d is voluntary. Justice. Neither agency intends to take
to the Federal Reserve’s operational and Because survey questions may differ any action with respect to these
fiscal agency responsibilities. The FR from survey to survey, it is difficult to proposed acquisitions during the
3054a may be conducted independently determine in advance whether the applicable waiting period.
VerDate Sep<11>2014 13:41 Feb 10, 2017 Jkt 241001 PO 00000 Frm 00035 Fmt 4703 Sfmt 4703 E:\FR\FM\13FEN1.SGM 13FEN1](https://thefederalregister.org/doc/82_FR_10512/page/1.svg)
![Federal Register / Vol. 82, No. 28 / Monday, February 13, 2017 / Notices 10487
FOR FURTHER INFORMATION CONTACT: Healthcare Cost and Utilization Project base on preventing readmissions by
Theresa Kingsberry, Program Support (HCUP) indicates that in 2011 there focusing on the primary care setting,
Specialist, Federal Trade Commission were approximately 3.3 million adult and provide insight on the components
Premerger Notification Office, Bureau of hospital readmissions in the United and themes that should be part of a re-
Competition, Room CC–5301, States. Adults covered by Medicare have engineered visit in primary care that
Washington, DC 20024, (202) 326–3100. the highest readmission rate (17.2 per will ultimately inform an effective
By direction of the Commission. 100 admissions), followed by adults intervention that can be tested in a
covered by Medicaid (14.6 per 100 diverse set of primary care clinics.
Donald S. Clark,
admissions) and privately insured To meet AHRQ’s goals and objectives,
Secretary. the agency awarded a task order to John
adults (8.7 per 100 admissions). High
[FR Doc. 2017–02892 Filed 2–10–17; 8:45 am] rates of readmissions are a major patient Snow, Inc. (JSI) to conduct a
BILLING CODE 6750–01–P safety problem associated with medical combination of qualitative research and
errors such as prescribing errors and quality improvement techniques to
misdiagnoses of conditions in the investigate the primary care-based
DEPARTMENT OF HEALTH AND hospital and ambulatory care settings. transitional care workflow from the
HUMAN SERVICES Collectively these readmissions are primary care staff, patient, and
associated with $41.3 billion in annual community agency perspective.
Agency for Healthcare Research and hospital costs, many of which could This research has the following goals:
Quality potentially be avoided. The post- 1. Analyze current processes in the
hospital discharge is a handoff ripe with primary care visit associated with
Agency Information Collection hazards, potentially leading to an array hospital discharge; and
Activities: Proposed Collection; of adverse events including the 2. Identify components of the re-
Comment Request development of new or worsening engineered visit.
AGENCY: Agency for Healthcare Research symptoms, unplanned readmissions, This study is being conducted by
and Quality, HHS. and increased costs. AHRQ through its contractor pursuant
In recent years, payer and provider to AHRQ’s statutory authority to
ACTION: Notice.
efforts to reduce readmissions have conduct and support research on health
SUMMARY: This notice announces the proliferated. Many of these national care and on systems for the delivery of
intention of the Agency for Healthcare programs have been informed or guided such care, including activities with
Research and Quality (AHRQ) to request by evidence-based research, toolkits and respect to the quality, effectiveness,
that the Office of Management and guides, such as AHRQ’s RED (Re- efficiency, appropriateness and vale of
Budget (OMB) approve the proposed Engineered Discharge), STAAR (State health care services and with respect to
information collection project ‘‘The Re- Action on Avoidable Readmission), quality measurement and improvement.
Engineered Visit for Primary Care AHRQ’s Project BOOST (Better 42 U.S.C. 299a(a)(1) and (2).
(AHRQ REV).’’ In accordance with the Outcomes by Optimizing Safe Method of Collection
Paperwork Reduction Act, AHRQ Transitions), the Hospital Guide to
Reducing Medicaid Readmissions, and To analyze current processes in the
invites the public to comment on this
Eric Coleman’s Care Transitions primary care visit associated with
proposed information collection.
Intervention. These efforts have largely hospital discharge, the data collection
DATES: Comments on this notice must be has separated into seven smaller data
focused on enhancing practices
received by April 14, 2017. collection activities to minimize
occurring within the hospital setting,
ADDRESSES: Written comments should including the discharge process and research participant burden while still
be submitted to: Doris Lefkowitz, handoffs to receiving providers or allowing for the collection of necessary
Reports Clearance Officer, AHRQ, by settings of care. While many of these data. Each of these tasks will be
email at doris.lefkowitz@AHRQ.hhs.gov. efforts have recognized the critical role conducted at nine primary care sites:
Copies of the proposed collection of primary care in managing care 1. Primary care site organizational
plans, data collection instruments, and transitions, they have not had an characteristics survey: The purpose of
specific details on the estimated burden explicit focus on enhancing primary this background information on the
can be obtained from the AHRQ Reports care with the aim of reducing avoidable primary care site’s organizational
Clearance Officer. readmissions. characteristics is to offer context for the
FOR FURTHER INFORMATION CONTACT: Evidence-based guidance for the work flow mapping. It will help make
Doris Lefkowitz, AHRQ Reports primary care setting to reduce the work flow mapping process more
Clearance Officer, (301) 427–1477, or by readmissions and improve patient safety efficient and reduce burden by only
emails at doris.lefkowitz@ are comparatively lacking, and this gap requesting information that is already
AHRQ.hhs.gov. in the literature is becoming more known by a site contact at each of the
pronounced as primary care is nine primary care practices. One person
SUPPLEMENTARY INFORMATION:
increasingly being called to serve as the per primary care site will be engaged for
Proposed Project key integrator role across the health this task.
system as part of payment and delivery 2. Primary care site patient
The Re-Engineered Visit for Primary characteristics survey: The purpose of
system reforms. This research project
Care (AHRQ REV) this background information on the
aims to address the important and
This project—The Re-engineered Visit primary care site’s patients is to offer
jstallworth on DSK7TPTVN1PROD with NOTICES
unfulfilled need to improve patient
for Primary Care (AHRQ REV)—directly safety and reduce avoidable context for the work flow mapping. It
addresses the agency’s goal to conduct readmissions within the primary care will help make the work flow mapping
research to enhance the quality of health context. process more efficient and reduce
care and reduction of avoidable AHRQ’s goals in supporting this 30- burden by only requesting information
readmissions, which are a major month project are to build on the that is already known in the primary
indicator of poor quality and patient knowledge base from the inpatient care practices’ billing or clinical
safety. Research from AHRQ’s settings, add to the expanding evidence information systems. One person per
VerDate Sep<11>2014 13:41 Feb 10, 2017 Jkt 241001 PO 00000 Frm 00038 Fmt 4703 Sfmt 4703 E:\FR\FM\13FEN1.SGM 13FEN1](https://thefederalregister.org/doc/82_FR_10512/page/4.svg)
Document Created: 2017-02-11 00:59:01
Document Modified: 2017-02-11 00:59:01
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Contact | Theresa Kingsberry, Program Support Specialist, Federal Trade Commission Premerger Notification Office, Bureau of Competition, Room CC-5301, Washington, DC 20024, (202) 326- 3100. | |
| FR Citation | 82 FR 10484 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR